Drugs / Infanrix Hib™
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01086423 Comparator | Mar → Nov 2010 | diphtheria, haemophilus infectious disease, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix-Hib | “received 3 doses of Infanrix™-Hib vaccine co-administered with Poliorix™ vaccine” NCT01086423 ↗ |
| Modality | Vaccine | “Infanrix™-Hib vaccine” NCT01086423 ↗ |
| Route | Intramuscular | “administered intramuscularly in the upper side of the right or left thigh, respectively” NCT01086423 ↗ |